Potential therapeutic and pharmacological strategies for SARS-CoV2

BACKGROUND: At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Investig
Main Authors: Ghareeb, Doaa A., Saleh, Samar R., Nofal, Mohammed S., Kaddah, Mohamed M. Y., Hassan, Salma. F., Seif, Inas K., El-Zahaby, Sally A., Khedr, Shaimaa M., Kenawy, Marwa Y., Masoud, Aliaa A., Soudi, Salma A., Sobhy, Ahmed A., Sery, Jaillan G., El-Wahab, Miral G. Abd, Elmoneam, Alshimaa A. Abd, Al-mahallawi, Abdulaziz Mohsen, El-Demellawy, Maha A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933375/
https://ncbi.nlm.nih.gov/pubmed/33688448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40005-021-00520-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados